🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 86627T108 (prev. 86627R102 )
- Market Cap
- Micro Cap
- IPO
- 3/4/2015 · $9.90/share
- ADR Ratio
- 1:5
- Previous Name
- Summit Therapeutics plc
Business: Summit Therapeutics Inc. is a biopharmaceutical company designing new mechanism antibiotics to be specific for the pathogen or infection. The Company believes this allows them to develop antibiotics capable of meeting the unmet needs of patients and healthcare providers, show clear advantages over current therapies and create value for payors and healthcare systems.
Company Contact
- CEO
- Bob Duggan
- CFO
- Ankur Dhingra
- CEO
- Maky Zanganeh
- Headquarters
- 601 Brickell Key Drive, Suite 1000, Miami FL 33131
- Phone
- 650-460-8308
- Investor Relations
- Dave Gancarz · 617-514-7149 · david.gancarz@smmttx.com